Tumor-infiltrating Lymphocytes Expression in Stage IIIc/IV of High-grade Serous Ovarian Cancer: Variation with Neoadjuvant Chemotherapy and Prognostic Value
K. Rojas, G. Prado-Vázquez, C. Bárcena, L. Trilla-Fuertes, A. Gámez-Pozo, A. Zapater-Moros, M. Ferrer-Gómez, L. Lema, R. García-Martin, A. Maroto, J. L. Rodríguez, C. Mendiola, Juan Ángel Fresno Vara, L. Paz-Ares
{"title":"Tumor-infiltrating Lymphocytes Expression in Stage IIIc/IV of High-grade Serous Ovarian Cancer: Variation with Neoadjuvant Chemotherapy and Prognostic Value","authors":"K. Rojas, G. Prado-Vázquez, C. Bárcena, L. Trilla-Fuertes, A. Gámez-Pozo, A. Zapater-Moros, M. Ferrer-Gómez, L. Lema, R. García-Martin, A. Maroto, J. L. Rodríguez, C. Mendiola, Juan Ángel Fresno Vara, L. Paz-Ares","doi":"10.35702/ONC.10008","DOIUrl":null,"url":null,"abstract":"1 Citation: Rojas K (2019). Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value. Oncogen Journal 2(2): 8. Tumor-infiltrating Lymphocytes Expression in Stage IIIc/IV of High-grade Serous Ovarian Cancer: Variation with Neoadjuvant Chemotherapy and Prognostic Value K Rojas1, G Prado-Vazquez2, C Barcena3, L Trilla-Fuertes2, A Gamez-Pozo 2,4, A Zapater-Moros4, M Ferrer-Gomez4, L Lema1, R Garcia-Martin3, A Maroto3, JL Rodriguez3, C Mendiola1, JA Fresno Vara4, L Paz-Ares1 1Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain. 2Biomedica Molecular Medicine SL, Madrid, Spain. 3Department of Pathology, Hospital 12 de Octubre, Madrid, Spain. 4Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, Hospital Universitario La Paz, Madrid, Spain.","PeriodicalId":92827,"journal":{"name":"Oncogen","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncogen","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35702/ONC.10008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
1 Citation: Rojas K (2019). Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value. Oncogen Journal 2(2): 8. Tumor-infiltrating Lymphocytes Expression in Stage IIIc/IV of High-grade Serous Ovarian Cancer: Variation with Neoadjuvant Chemotherapy and Prognostic Value K Rojas1, G Prado-Vazquez2, C Barcena3, L Trilla-Fuertes2, A Gamez-Pozo 2,4, A Zapater-Moros4, M Ferrer-Gomez4, L Lema1, R Garcia-Martin3, A Maroto3, JL Rodriguez3, C Mendiola1, JA Fresno Vara4, L Paz-Ares1 1Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain. 2Biomedica Molecular Medicine SL, Madrid, Spain. 3Department of Pathology, Hospital 12 de Octubre, Madrid, Spain. 4Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, Hospital Universitario La Paz, Madrid, Spain.
1引用本文:Rojas K(2019)。高级别浆液性卵巢癌IIIc/IV期肿瘤浸润淋巴细胞表达:随新辅助化疗的变化及预后价值中华肿瘤杂志2(2):8。高级别浆液性卵巢癌IIIc/IV期肿瘤浸润淋巴细胞的表达K Rojas1, G Prado-Vazquez2, C Barcena3, L Trilla-Fuertes2, A Gamez-Pozo 2,4, A zapatermoros4, M Ferrer-Gomez4, L Lema1, R Garcia-Martin3, A Maroto3, JL Rodriguez3, C Mendiola1, JA Fresno Vara4, L Paz-Ares1 1新辅助化疗的变异与预后价值1马德里10月12日医院肿瘤内科，C Mendiola1, JA Fresno Vara4, L paz - are1 2马德里生物医学分子医学SL，西班牙。医学和分子遗传学研究所，拉巴斯医院大学，马德里，西班牙。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
